Eli Lilly’s Taltz proves best in show for Palmoplanter Psoriasis sufferers 

​Very impressive results for this fairly new drug named Taltz.  For most patients, hand and foot psoriasis can be very frustrating.  Nothing seems to work for these areas.  I know of three medications that are somewhat effective.  

However, Taltz is taking no prisoners when it comes to palmoplanter psoriasis which affects the hands a soles of the feet.  According to the research, during the 12 week study, 50% of patients cleared 100% (PPASI score).  

As a patient Influencer I’m happy to report this information to the psoriasis community.  It breaks my heart to see people suffering in this capacity.  I feel their pain, because I’ve experienced it.  
The best news is that it has a track record for maintaining it’s effectiveness for 60 consecutive weeks.  This is pivotal for people with palmoplanter psoriasis.   Dr. Mentor is a specialist when it comes to all types of psoriasis.  

If you’re newly diagnosed join our support group call Overcoming Psoriasis <<click on hyper-link
The recommended dosing for Taltz is an initial 160 milligrams (mg) subcutaneous (SC) injection followed by an 80mg SC injection once every two weeks for 12 weeks, then 80mg every four weeks. Taltz is a little more convenient then other anti-IL-17A medications for psoriasis.

Dr. Menter’s article is in the link provided.

Taltz (ixekizumab) Can Improve Palmoplantar Psoriasis For Up To 60 Weeks

#palmoplanter #Taltz #Lilly #psoriasis #psoriaticarthritis #NPF 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s